Stocks
Themes
Market Cap Ranking
Trading Strategies
SEC Filings TLDR
Analysis Reports
Sign in
Loading stock data...
Loading updates and signals...
Back
ARVN
$9.59
+0.95%
Analyze
1M
+16.0%
3M
+22.3%
1Y
-63.0%
Market Cap:
$704.08M
Arvinas Inc
Healthcare |
Biotechnology
Arvinas, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of therapies to break down disease-causing proteins. The company is headquartered in New Haven, Connecticut.
Click "Analyze" to generate stock analysis
ARVN Price Trend and Signals
ARVN Option Volumes & Open Interests (aggregated)
ARVN Put Call Ratios and IV (aggregated)
ARVN Financials
Signals
News
SEC Filings
Holders
Research Reports
AI Analysis
2025-10-20
Somewhat Bearish
macd_signal
Dead cross above zero detected.
2025-10-13
Somewhat Bullish
price_signal
Half-yearly high detected.